BioSpace - Zalicus Inc. News, Search Jobs, Events

BioSpace Collaborative

Academic/Biomedical Research
News & Jobs

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

<script language="javascript" src="http://at.ontargetjobs.com/addyn/3.0/701/2449103/0/681/ADTECH;loc=700;target=_blank;key=key1+key2+key3+key4;grp=[group]"></script><noscript><a href="http://at.ontargetjobs.com/adlink/3.0/701/2449103/0/681/ADTECH;loc=300;key=key1+key2+key3+key4;grp=[group]" target="_blank"><img src="http://at.ontargetjobs.com/adserv/3.0/701/2449103/0/681/ADTECH;loc=300;key=key1+key2+key3+key4;grp=[group]" border="0" width="160" height="240"></a></noscript>

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile

Zalicus Inc.

245 First Street
Third Floor
Cambridge Massachusetts 02142 U.S.A.
Phone: 617-301-7000 Fax: 617-301-7010

View Clinical Trials from BioPharm Insight

Zalicus (Nasdaq: ZLCS) is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Zalicus has a portfolio of proprietary clinical-stage product candidates targeting pain and immuno-inflammatory diseases and has entered into multiple revenue-generating collaborations with large pharmaceutical companies relating to other products, product candidates and drug discovery technologies. Zalicus applies its expertise in the discovery and development of selective Ion channel modulators and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators in the areas of pain, inflammation, oncology and infectious disease. To learn more about Zalicus, please visit www.zalicus.com. Zalicus is a public company with 40 employees.

Key Statistics

Email: information@zalicus.com
Ownership: Public

Web Site: Zalicus Inc.
Employees: 102
Symbol: ZLCS

Industry
Biopharmaceutical

Segment
Research and Development

Company News

Zalicus Inc. (ZLCS) Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain 5/10/2013 11:27:30 AM More...

Zalicus Inc. (ZLCS) Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain 5/10/2013 7:58:23 AM More...

Zalicus Inc. (ZLCS) Enters $25 Million Committed Funding Agreement 5/8/2013 6:52:34 AM More...

Zalicus Inc. (ZLCS) Reports Financial Results for the First Quarter 2013 5/2/2013 8:18:46 AM More...

Zalicus Inc. (ZLCS) Granted Key Formulation Patent for Z160 4/2/2013 9:51:07 AM More...

Zalicus Inc. (ZLCS) Presents Data Demonstrating Advantages of State-Dependent Ion Channel Screening 3/19/2013 9:38:07 AM More...

Zalicus Inc. (ZLCS) Reports Financial Results for the Fourth Quarter and Year End 2012 3/6/2013 6:22:44 AM More...

Zalicus Inc. (ZLCS) Granted Composition-of-Matter Patent for Z944 2/20/2013 10:34:58 AM More...

Zalicus Inc. (ZLCS) to Present at the 2013 Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/5/2013 7:05:17 AM More...

Zalicus Inc. (ZLCS) Initiates the Second of Two Phase 2a Studies With Z160 1/3/2013 9:04:10 AM More...

1